Pharmacological Activation of Pyruvate Kinase M2 Inhibits CD4+ T Cell Pathogenicity and Suppresses Autoimmunity.

Journal: Cell Metabolism

Published: 2019-11-20

DOI: 10.1016/j.cmet.2019.10.015

Affiliations: 3

Authors: 11

Go to article
Institutions Share
Trinity Biomedical Sciences Institute (TBSI), TCD, Ireland 0.64
Max Planck Institute of Immunobiology and Epigenetics (MPI-IE), Germany 0.27
Center of Basic Research, Academy of Athens, Greece 0.09